Although Quest continues to make progress in reducing the backlog they are focused on making the following changes within the next two to three weeks which will positively impact turnaround times:
- Quest is implementing a second shift for processing specimens and they should be fully staffed by late October. This should result in increased testing capacity and improved TAT.
- An additional screening instrument is being operationalized within the next few days that will enhance the number of specimens which can screen at a time.
- Adding tenured staff to "negative certification" department which will start within the next two weeks. this will prove a big boost to Quest's ability to see improved TAT on specimens.
Lastly, due to the current climate around the global shortage of raw materials, staffing, logistical constraints, and bottlenecks in international shipping, operations and fulfillment of supply orders are being negatively affected.
To address these continuing challenges we need to ensure that reasonable expectations are set regarding how your supply orders are being affected:
- Quest expects the current effects of global supply chain constraints to exist for another 6-12 months. This timeline is not wholly unprecedented or unique to drug testing supplies.
- Please work with your account manager to address any priority orders.
- Take inventory of Quest supplies and submit replacement orders at least two months prior to when you anticipate needing a replacement of supplies.
We are sharing this information from our partner to help better navigate these challenging times. Truescreen continues to monitor the situation and will provide updates as they become available.
If you have any questions, please contact your sales executive, account manager, or our customer service team.
Posted: October 19, 2021